P. Hellamand Et Al. , "SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK," ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.257-259, 2022
Hellamand, P. Et Al. 2022. SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 257-259.
Hellamand, P., De Sande, M. G. H. V., Ornbjerg, L. M., Klausch, T., Trokovic, N., Sokka-Isler, T., ... Santos, M. J.(2022). SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 257-259.
Hellamand, P. Et Al. "SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 257-259, 2022
Hellamand, P. Et Al. "SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.257-259, 2022
Hellamand, P. Et Al. (2022) . "SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.257-259.
@article{article, author={P. Hellamand Et Al. }, title={SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={257-259} }